Conscious Investing Today
  • Top News
  • Business Insider
  • Economic Indicators
  • Investing Ideas
  • Politics News
  • Stock Analysis
  • Editor’s Pick
No Result
View All Result
  • Top News
  • Business Insider
  • Economic Indicators
  • Investing Ideas
  • Politics News
  • Stock Analysis
  • Editor’s Pick
No Result
View All Result
Conscious Investing Today
No Result
View All Result
Home Politics News

Wrongheaded: Private import of vaccines ‘at will’

by
April 11, 2021
in Politics News
0
Wrongheaded: Private import of vaccines ‘at will’
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT
FREEPIK

“I ordered Secretary Galvez to sign any and all documents that would allow the private sector to import at will.”

President Rodrigo Duterte delivered said statement on March 29, 2021 to accommodate the lobby of some corporations to procure and import their own vaccines. Soon after, an organization called Act As One issued a position paper as follows:

“We humbly call on Congress to revisit Section 5 of Republic Act No. 11525, otherwise known as the ‘COVID-19 Vaccination Program Act of 2021.’ The requirement in said law for a multiparty agreement with the Philippine government before private entities may procure COVID-19 vaccine is just another bureaucratic layer that prevents the urgent influx of authorized vaccines here in the Philippines.

“Government regulations and monitoring should still be in place but there should be minimal government intervention in the procurement stage. Allowing the private sector to import vaccine without burdensome restrictions will also be in consonance with the President’s directive that the private sector should be allowed to import vaccines ‘at will.'”

One thing is clear: For the private sector to “import at will,” the law will first have to be amended. But this is a wrong policy, which this article will try to show.

Immunization against COVID-19 of the whole population is a public good. To be accurate, it is not just a public good; it is a global public good. The vaccination of all peoples in all countries is necessary for the realization of herd immunity.

Two basic characteristics define a public good. First, a public good is non-excludable. Second, it is non-rivalrous.

Towards achieving herd immunity, no adult person can be excluded from the benefits of vaccination. The governments must ensure that everyone, including those who are poor or who cannot afford vaccines, will get inoculated. The risk of a person getting COVID-19 is vastly diminished when almost everyone is immunized.

Further, one person’s immunization neither rivals nor prevents the immunization of others. Further, the vaccination of many even enhances the benefits for one individual (the gains from herd immunity). Thus, immunization is non-rivalrous or even anti-rivalrous.

Another way to look at immunization as a public good is that it addresses what is called an externality. A communicable disease like COVID-19 is harmful and costly not only to the infected individual but to the rest of society. The infection exponentially spreads. The cost to the many others is the negative externality.

Immunization on the other hand is a positive externality. That is, it protects not only the health of an infected individual but also gives benefits to other members of society by stemming the further spread of the disease.

That immunization is a public good makes a strong case for governments to freely provide the population the vaccines.

It is most unfortunate though that the early failure of the Philippine National Government to immediately procure the vaccines compelled the private sector and the local government units (LGUs) to act on their own. They took the initiative of trying to get the vaccines for their workers and constituents.

As a result, a second-best solution emerged in which the National Government allowed the private sector and the LGUs to procure vaccines by way of a tripartite agreement. Through this agreement, the National Government, the LGUs, and the private corporations will pool their resources to procure the vaccines. Certainly, the negotiations and procurement will be done by the National Government.

But President Duterte’s statement that the private sector can “import at will” undermines the tripartite agreement. It likewise contradicts the underlying principle that treats immunization as a public good.

We can cite many reasons why “import at will” is misguided and injurious.

First, all vaccines are for emergency use authority (EUA). The vaccines are still undergoing trials and therefore cannot be deemed commercial.

Second, precisely because vaccines are all subject to EUA, vaccine manufacturers will only deal with the government. They want legal guarantees. They require indemnification clauses. Which government, not the private sector, can provide.

Third, some argue that the government is not doing a good job in the vaccination rollout, but this needs a more nuanced treatment. It assumes that the private sector can do better.

But the rollout itself faces objective constraints, regardless of who is involved. To wit:

The majority of the people, including many health workers, do not want to be vaccinated.

Global supply is limited, and the rich countries have taken a disproportionately big share of the scarce supply.

The health system is currently overwhelmed by the new virus wave, which further impedes the vaccination implementation.

Private sector procurement of vaccines will not solve the major constraints cited above.

Fourth, having a “free market” for the vaccines undermines the prioritization program for vaccination. Some think that the prioritization is meant to satisfy equity. Yes, equity matters. But that’s not all to it.

Giving priority to the health workers, the elderly, those with comorbidities, and the poor will also result in efficient outcomes. Those being prioritized are the most vulnerable to infection. They, too, are a main source of spreading infection.

Fifth, still in line with the argument for efficiency, the government can negotiate lower prices. The government has the monopsony power to bring down vaccine prices. Letting the private sector do its own procurement will result in variable prices that cannot approximate what the government can get. The tripartite agreement that enables the pooling of resources for procurement is thus sensible.

Sixth, in pricing the vaccines, the parties need to internalize the myriad costs. The price in doing immunization is not limited to the vaccines. Take into account the transaction costs. Take into account the other costs for the immunization pathway.

ADVERTISEMENT

Other costs include the hiring of workers who will administer the vaccines, the training of these workers, the transportation and communications expenses, the storage costs, etc. In a word, private sector procurement will be costlier, and probably less efficient because this kind of process is not its specialization.

Seventh, precisely because the cost consideration is not just limited to buying the vaccines, the substantial costs should compel the private sector to think about the opportunity costs.

Given that the government will anyway spend for a public good (that is, the vaccines), wouldn’t it be much better for the private sector to allocate their additional funds to interventions that will put in place the health and safety standards in the offices and factories toward containing the pandemic? Shouldn’t the private sector be spending on benefits for sick workers (thus giving incentives to symptomatic workers to stay at home), installing filtration or ventilation systems, and redesigning workplaces to deal with airborne virus transmission?

As one young smart health professional told me: “Can’t the private sector think of funding instead the vaccination itself rather than the purchase of the vaccines? We need more hands (literally and figuratively) injecting doses as we receive the bulk of vaccines in the coming months.” And if resources are still available, the private sector could help fund the minimum public health standards.

Vaccination, too, is not a one-off activity. That the vaccines are all undergoing trial signifies activities beyond administering the jabs. Immunization entails a pathway for a longer-term program.

In this regard, the vaccination strategy has to be done in conjunction with building primary healthcare. The vaccination program is an opportunity to put Universal Health Care (UHC) into action by way of strengthening primary care.

This, of course, necessitates cooperation and partnership with LGUs and the private sector.

The government and the private sector must know what their respective comparative advantages are. Immunization is a public good. The private sector cannot supplant the government in providing a public good.

Allowing the private sector to import vaccines “at will” does not lead to efficient and equitable outcomes. Instead, it results in less bang for the buck.

Filomeno S. Sta. Ana III coordinates the Action for Economic Reforms.

www.aer.ph

Related Posts

G7 aims to raise $600 billion to counter China’s Belt and Road
Politics News

G7 aims to raise $600 billion to counter China’s Belt and Road

June 27, 2022
Measuring economic prospects through the growing demand for credit
Politics News

Measuring economic prospects through the growing demand for credit

June 27, 2022
Why credit scores matter to financial health
Politics News

Why credit scores matter to financial health

June 27, 2022
Next Post
EO 128 is not that bad for producers

EO 128 is not that bad for producers

A pork crisis averted... for now

DoT to propose adoption of IATA Travel Pass to IATF

DoT to propose adoption of IATA Travel Pass to IATF

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Categories

  • Economic Indicators
  • Editor's Pick
  • Investing Ideas
  • Politics News
  • Stock Analysis

Popular News

  • A Minute With: Family Reunion cast on relatable story lines

    A Minute With: Family Reunion cast on relatable story lines

    0 shares
    Share 0 Tweet 0
  • Twitter launches ‘Milk Tea Alliance’ emoji as movement grows

    0 shares
    Share 0 Tweet 0
  • Gas and car bills to soar under green revolution

    0 shares
    Share 0 Tweet 0
  • Level up your gaming experience with vivo Y20s [G]

    0 shares
    Share 0 Tweet 0
  • Rehab, expansion of General Santos airport seen completed by Q2

    0 shares
    Share 0 Tweet 0
No Result
View All Result

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Highlights

Hamilo Coast: Nurturing nature for 15 years and beyond

Abortion ruling casts cloud over usual cheer at US Pride parades

Driving social inclusion and using Tech4Good: Globe wins in 2022 ASEAN Tech for ESG Awards

Axelum Resources Corp. to conduct annual stockholders’ meeting on July 29 via remote communication

SEC warns public vs investing in three entities

SSC outlasts Perpetual Help in 5 sets, shares second spot

Trending

G7 aims to raise $600 billion to counter China’s Belt and Road
Politics News

G7 aims to raise $600 billion to counter China’s Belt and Road

by
June 27, 2022
0

JCOMP-FREEPIK SCHLOSS ELMAU, Germany — Group of Seven (G7) leaders on Sunday pledged to raise $600 billion...

Measuring economic prospects through the growing demand for credit

Measuring economic prospects through the growing demand for credit

June 27, 2022
Why credit scores matter to financial health

Why credit scores matter to financial health

June 27, 2022
Hamilo Coast: Nurturing nature for 15 years and beyond

Hamilo Coast: Nurturing nature for 15 years and beyond

June 27, 2022
Abortion ruling casts cloud over usual cheer at US Pride parades

Abortion ruling casts cloud over usual cheer at US Pride parades

June 27, 2022

Disclaimer: ConsciousInvestingToday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Home
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • Email Whitelisting

Copyright © 2021 ConsciousInvestingToday. All Rights Reserved.

No Result
View All Result
  • Home
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • Email Whitelisting

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.